Colorectal

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
40015
Irinotecan combined with infusional 5-FU/Folinic acid or Capecitabine and the role of Celecoxib in patients with metastatic colorectal cancer
40051
Randomized phase II trial evaluating the feasibility and tolerance of the combination of FOLFOX with cetuximab and the combination of FOLFOX with cetuximab and bevacizumab as perioperative treatment in patients with resectable liver metastases from colorectal cancer (BOS).
16029
Phase I study of PS-341 (VELCADE)in combination with 5FU/LV plus oxaliplatin in patients with advanced colorectal cancer
16033
A phase I study of OSI-7904L in combination with oxaliplatin in patients with advanced colo-rectal cancer

Back to Site-list